Study #2019-0978
Patient-Centered Liver Cancer Prevention in the Houston Community - Screening for Fibrosis and Cirrhosis
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This clinical trial studies the use of surveys, blood testing, and fibroscan in screening for liver fibrosis and liver cirrhosis in new or existing patients of the HOPE clinic seeking usual clinical care. Fibroscan is an imaging procedure of the liver which uses a probe like an ultrasound. Information gathered from this study may help researchers learn more about how to prevent or find liver cancer in patients who are currently receiving care at the HOPE clinic. Early detection of liver cancer may improve survival.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Liver and Intrahepatic Bile Duct Carcinoma
Study phase:
Not applicable
Physician name:
Jessica Hwang
Department:
General Internal Medicine
For general questions about clinical trials:
1-866-254-1401
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.